Market Tracker

07/26 4:08am ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

4.14
Delayed Data
As of Jul 25
 +0.07 / +1.72%
Today’s Change
3.34
Today|||52-Week Range
8.79
-40.26%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close4.07
Today’s open4.18
Day’s range4.09 - 4.26
Volume68,898
Average volume (3 months)41,896
Market cap$54.2M
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+43.37%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NWBONorthwest Biotherape...-0.02-4.48%
CATBCatabasis Pharmaceut...+0.10+2.68%
EBIOEleven Biotherapeuti...+0.39+14.50%
RNNRexahn Pharmaceutica...+0.00+0.43%
Data as of 07/25/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts